Write a comment
The achievements of the Chairman of Newry Cancer Research Committee and his team were recently acknowledged by Newry, Mourne and Down District Council who hosted a reception for the group. Council Chairperson, Cllr Valerie Harte hosted the Civic Reception in Newry Civic Centre 29 June to mark the outstanding fundraising achievements of Newry Cancer Research Committee.
Formed in 1978, the Committee has been a beacon of light in the fight against cancer. It is well-respected throughout the community for its unwavering dedication and commitment to raising money for Cancer Research UK and over the last 45 years it has raised over £1million for the charity.
Chairman, Gervase McCartan is its longest serving member and together with the rest of the members they have been instrumental in fostering relationships with businesses and individuals across Newry and the wider area. Their portfolio has grown over the years and includes an extensive range of fundraising activities such as street collections, big breakfasts, golf days, coffee mornings, spinathons, charity walks, skydiving, bingo nights, and pub quizzes. There is plenty of fun along the way but they never lose sight of their ultimate goal.
Newry, Mourne and Down District Council Chairperson, Councillor Valerie Harte said, “The committee members have been willing to give their time to this noble cause. Sadly, some of them are no longer with us but we offer sincere thanks and gratitude to those who have served and are still serving.
“The impact of Newry Cancer Research Committee is immeasurable, and they are an inspiration to us all. We can all learn from their example and join forces with them to fight against this disease.”
Newry Cancer Committee Chairman, Gervase McCartan said, “All monies raised by Newry Cancer Committee remain in Northern Ireland and last year Cancer Research UK spent over £2m in the region. The impact of our work over the last 40 years is evident in the fact that cancer survival has doubled. In the 1970s, only one in four people survived their disease for 10 years or more, but today, two in four survive. The charity aims to accelerate progress and see three in four surviving the disease by 2034.
“Our efforts are a testament to the power of community and the difference that can be made when people come together for a common cause.”
